BELLUS Health Inc.
BLUNASDAQHealthcare
$14.75
+$0.01(+0.03%)
Market Cap$1.9B
P/E Ratio—
52W High$14.76
52W Low$6.38
BELLUS Health Inc. (BLU) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLU · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 13, 2023EPS Actual
-$0.08
Revenue
$1.22B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 13, 2023
After Market Close
✓ 3-Quarter EPS Beat Streak
BLU reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 10, 2024 | — | — | — | — | — | — |
| — Q4 FY2023 | Nov 13, 2023 | — | -$0.08 | — | $1.22B | — | — |
| ▲ Q3 FY2023 | Aug 9, 2023 | -$0.24 | -$0.18 | +25.0% | $1.15B | — | — |
| — Q2 FY2023 | May 12, 2023 | -$0.20 | -$0.20 | +0.0% | $0.00B | — | — |
| ▲ Q1 FY2023 | Mar 21, 2023 | -$0.19 | -$0.15 | +21.1% | $0.00B | — | — |
| ▼ Q4 FY2022 | Nov 14, 2022 | -$0.18 | -$0.20 | -11.1% | $0.00B | — | — |
| ▼ Q3 FY2022 | Aug 10, 2022 | -$0.16 | -$0.18 | -12.5% | $0.00B | — | — |
| ▲ Q2 FY2022 | May 11, 2022 | -$0.18 | -$0.13 | +27.8% | $0.00B | $0.00B | -37.4% |
Q2 FY2024
May 10, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$1.22B
Q3 FY2023
Aug 9, 2023Beat
EPS Actual
-$0.18
EPS Est.
-$0.24
EPS Surpr.
+25.0%
Revenue
$1.15B
Q2 FY2023
May 12, 2023
EPS Actual
-$0.20
EPS Est.
-$0.20
EPS Surpr.
+0.0%
Revenue
$0.00B
Q1 FY2023
Mar 21, 2023Beat
EPS Actual
-$0.15
EPS Est.
-$0.19
EPS Surpr.
+21.1%
Revenue
$0.00B
Q4 FY2022
Nov 14, 2022Miss
EPS Actual
-$0.20
EPS Est.
-$0.18
EPS Surpr.
-11.1%
Revenue
$0.00B
Q3 FY2022
Aug 10, 2022Miss
EPS Actual
-$0.18
EPS Est.
-$0.16
EPS Surpr.
-12.5%
Revenue
$0.00B
Q2 FY2022
May 11, 2022Beat
EPS Actual
-$0.13
EPS Est.
-$0.18
EPS Surpr.
+27.8%
Revenue
$0.00B
No analyst estimates available for BLU.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Nov 13, 2023 | — | $14.74 | — | — |
| ▲ Q3 FY2023 | Aug 9, 2023 | +25.0% | $14.74 | — | — |
| ▲ Q2 FY2023 | May 12, 2023 | +0.0% | $14.49 | $14.48 | -0.07% |
| ▲ Q1 FY2023 | Mar 21, 2023 | +21.1% | $7.61 | $7.72 | +1.45% |
| ▼ Q4 FY2022 | Nov 14, 2022 | -11.1% | $9.29 | $9.06 | -2.48% |
| ▼ Q3 FY2022 | Aug 10, 2022 | -12.5% | $11.59 | $11.86 | +2.33% |
| ▲ Q2 FY2022 | May 11, 2022 | +27.8% | $6.73 | $6.78 | +0.74% |
| ▲ Q1 FY2022 | Feb 23, 2022 | +30.8% | $6.38 | $6.00 | -5.96% |
Q4 FY2023—
Report Date
Nov 13, 2023
EPS Beat/Miss
—
Price Before
$14.74
Price After
—
Q3 FY2023—
Report Date
Aug 9, 2023
EPS Beat/Miss
+25.0%
Price Before
$14.74
Price After
—
Q2 FY2023-0.07%
Report Date
May 12, 2023
EPS Beat/Miss
+0.0%
Price Before
$14.49
Price After
$14.48
Q1 FY2023+1.45%
Report Date
Mar 21, 2023
EPS Beat/Miss
+21.1%
Price Before
$7.61
Price After
$7.72
Q4 FY2022-2.48%
Report Date
Nov 14, 2022
EPS Beat/Miss
-11.1%
Price Before
$9.29
Price After
$9.06
Q3 FY2022+2.33%
Report Date
Aug 10, 2022
EPS Beat/Miss
-12.5%
Price Before
$11.59
Price After
$11.86
Q2 FY2022+0.74%
Report Date
May 11, 2022
EPS Beat/Miss
+27.8%
Price Before
$6.73
Price After
$6.78
Q1 FY2022-5.96%
Report Date
Feb 23, 2022
EPS Beat/Miss
+30.8%
Price Before
$6.38
Price After
$6.00
Avg Beat Reaction-0.96%
Avg Miss Reaction-0.07%
Beat Rate5 / 8 quarters
Largest Move-5.96% (Q1 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLU ends December
BELLUS Health Inc. (BLU) most recently reported earnings on November 13, 2023 for Q4 FY2023, posting EPS of $-0.08 (in line with the analyst consensus of —). BLU has beaten EPS estimates for 3 consecutive quarters. The next BLU earnings date is expected around September 1, 2026.
Each quarter, investors track BLU earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLU revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLU's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLU earnings · 4 questionsBELLUS Health Inc.'s next earnings report is expected around September 1, 2026. BLU typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLU historically reports after market close (AMC).
BLU earnings datewhen is BLU earningsBLU next earnings datewhen does BLU report earningsBLU earnings calendar
▸ Source: FMP · BELLUS Health Inc. SEC filings · US GAAP · BELLUS Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026